LGND Covered Call Strategy
LGND (Ligand Pharmaceuticals Incorporated), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For hematologic malignancies, these include Kyprolis and Evomela, both targeting multiple myeloma, as well as Rylaze, a treatment for acute lymphoblastic leukemia and lymphoblastic lymphoma in both adult and pediatric patients. In the realm of infectious diseases, Ligand offers Veklury for moderate to severe COVID-19, Vaxneuvance for preventing invasive Streptococcus pneumoniae disease, and Pneumosil, a pneumococcal conjugate vaccine designed to protect children from pneumonia. Bone health solutions comprise Teriparatide injection for osteoporosis and Duavee for postmenopausal osteoporosis. Other key offerings include Zulresso, a Captisol-enabled formulation of brexanolone for postpartum depression; Nexterone, a Captisol-enabled amiodarone; and Noxafil-IV, a Captisol-enabled posaconazole for intravenous administration.
LGND (Ligand Pharmaceuticals Incorporated) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $5.88B, a trailing P/E of 29.83, a beta of 0.98 versus the broader market, a 52-week range of 149.51-326.63, average daily share volume of 318K, a public-listing history dating back to 1992, approximately 47 full-time employees. These structural characteristics shape how LGND stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.98 places LGND roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. LGND pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a covered call on LGND?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
LGND snapshot
As of August 14, 2026, spot at $292.75, ATM IV 37.40%, IV rank 14.50%, expected move 10.72%. The covered call on LGND below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on LGND specifically: LGND IV at 37.40% is on the cheap side of its 1-year range, which means a premium-selling LGND covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 10.72% (roughly $31.39 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LGND expiries trade a higher absolute premium for lower per-day decay. Position sizing on LGND should anchor to the underlying notional of $292.75 per share and to the trader's directional view on LGND stock.
LGND covered call setup
The LGND covered call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LGND at $292.75 on that close, the first option leg uses a $310.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LGND chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LGND shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $292.75 | long |
| Sell 1 | Call | $310.00 | $7.35 |
LGND covered call risk and reward
- Net Premium / Debit
- -$28,540.00
- Max Profit (per contract)
- $2,460.00
- Max Loss (per contract)
- -$28,539.00
- Breakeven(s)
- $285.40
- Risk / Reward Ratio
- 0.086
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
LGND covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on LGND. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$28,539.00 |
| $64.74 | -77.9% | -$22,066.25 |
| $129.47 | -55.8% | -$15,593.49 |
| $194.19 | -33.7% | -$9,120.74 |
| $258.92 | -11.6% | -$2,647.98 |
| $323.65 | +10.6% | +$2,460.00 |
| $388.38 | +32.7% | +$2,460.00 |
| $453.10 | +54.8% | +$2,460.00 |
| $517.83 | +76.9% | +$2,460.00 |
| $582.56 | +99.0% | +$2,460.00 |
When traders use covered call on LGND
Covered calls on LGND are an income strategy run on existing LGND stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
LGND thesis for this covered call
The market-implied 1-standard-deviation range for LGND extends from approximately $261.36 on the downside to $324.14 on the upside. A LGND covered call collects premium on an existing long LGND position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether LGND will breach that level within the expiration window. Current LGND IV rank near 14.50% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on LGND at 37.40%. As a Healthcare name, LGND options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LGND-specific events.
LGND covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LGND positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LGND alongside the broader basket even when LGND-specific fundamentals are unchanged. Short-premium structures like a covered call on LGND carry tail risk when realized volatility exceeds the implied move; review historical LGND earnings reactions and macro stress periods before sizing. Always rebuild the position from current LGND chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on LGND?
- A covered call on LGND is the covered call strategy applied to LGND (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With LGND stock at $292.75 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed LGND chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are LGND covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the LGND covered call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 37.40%), the computed maximum profit is $2,460.00 per contract and the computed maximum loss is -$28,539.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a LGND covered call?
- The breakeven for the LGND covered call priced on this page is roughly $285.40 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The LGND market-implied 1-standard-deviation expected move in the same options snapshot is approximately 10.72%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on LGND?
- Covered calls on LGND are an income strategy run on existing LGND stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current LGND implied volatility affect this covered call?
- LGND ATM IV is at 37.40% with IV rank near 14.50%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.